Page 28 - Pfizer
Wall Street rallies on first positive data from coronavirus vaccine trial
NEW YORK (Reuters) - The S&P 500 and the Dow rallied sharply but closed shy of their records on Monday as investors bet that a full economic reopening was finally in sight following the first positive data from a late-stage COVID-19 vaccine trial.
 "Wall Street rallies on first positive data from coronavirus vaccine trial")
Cautious excitement, relief after Pfizer vaccine result: What happens next?
The vaccine is the first to be tested in the United States to generate late-stage data
 "Cautious excitement, relief after Pfizer vaccine result: What happens next?")
Gold plunges 5% over Covid-19 vaccine success as investors dump bullion
Spot prices beat a sharp retreat from a near two-month peak of $1,965.33 hit earlier in the session amid a weaker dollar
 "Gold plunges 5% over Covid-19 vaccine success as investors dump bullion")
Pfizer's early data shows Covid-19 vaccine is more than 90% effective
Experts caution against hyping early results
 "Pfizer's early data shows Covid-19 vaccine is more than 90% effective")
Pfizer's Covid vaccine effectiveness claims inject hope, lift global stocks
Firms hit hardest by restrictions made most gains, with airlines trading 30% higher
 "Pfizer's Covid vaccine effectiveness claims inject hope, lift global stocks")
Double-edged news
Pfizer's vaccine is not necessarily great news for India
 "Double-edged news")
'Great day for humanity': Pfizer says Covid-19 vaccine over 90% effective
President-elect Joe Biden said the news was excellent but did not change the fact that face masks, social distancing would be needed well into next year
 "'Great day for humanity': Pfizer says Covid-19 vaccine over 90% effective")
Cost, timeline: Facts about Pfizer-BioNTech's '90% effective' Covid vaccine
The companies said the vaccine was more than 90% effective and they have so far found no serious safety concerns, priming it for possible speedy regulatory approvals
 "Cost, timeline: Facts about Pfizer-BioNTech's '90% effective' Covid vaccine")
Sputnik V vaccine is over 90% effective, says Russia's health ministry
The comments followed a statement earlier on Monday by vaccine developers Pfizer Inc and BioNTech, who said their experimental Covid-19 vaccine was more than 90% effective
 "Sputnik V vaccine is over 90% effective, says Russia's health ministry")
Biden focuses on tackling US coronavirus pandemic, hails vaccine progress
He labeled as "great news" Pfizer Inc's announcement on Monday that its experimental Covid-19 vaccine was more than 90% effective
 "Biden focuses on tackling US coronavirus pandemic, hails vaccine progress")
EU drug regulator says it is assessing early data from Pfizer Covid vaccine
The European Medicines Agency (EMA) started a rolling review of data from trials on the vaccine in early October.
Pfizer, BioNTech say their Covid-19 vaccine is more than 90% effective
Pfizer and BioNTech SE are first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine
 "Pfizer, BioNTech say their Covid-19 vaccine is more than 90% effective")
Pfizer's Covid vaccine candidate prevents 90% of infections in large study
The findings are based on an interim analysis conducted after 94 participants contracted Covid-19
Pfizer says no Covid vaccine data yet, unlikely to come before US elections
An independent panel will conduct the first analysis when it reaches 32 infections.
 "Pfizer says no Covid vaccine data yet, unlikely to come before US elections")
UK starts real-time review of Moderna's Covid-19 vaccine candidate
Moderna said earlier this month it was going to apply for real-time reviews of its experimental Covid-19 vaccine to Europe, following rolling reviews of shots of its rivals Pfizer Inc and AstraZeneca
 "UK starts real-time review of Moderna's Covid-19 vaccine candidate")
Drugmaker Pfizer not yet ready to release Covid-19 vaccine data
Pfizer said in a presentation that the independent monitor which will determine whether or not the trial has been successful has not conducted any interim efficacy analyses yet
 "Drugmaker Pfizer not yet ready to release Covid-19 vaccine data")
Pfizer says earliest US filing for Covid-19 vaccine would be late November
People around the world are counting on a vaccine to control the spread of the coronavirus, which has killed more than a million people and ravaged the global economy
Pfizer confirms possible November coronavirus vaccine application
Safety review dictates the timeline, with the Food and Drug Administration requiring that at least half the people in the study be watched for side effects for two months
 "Pfizer confirms possible November coronavirus vaccine application")
Pfizer could apply for emergency use of Covid-19 vaccine by late Nov
It would be the first time that Pfizer or any other leading Western vaccine developer provided such a specific timeline.
 "Pfizer could apply for emergency use of Covid-19 vaccine by late Nov")
New Zealand signs deal with Pfizer, BioNTech for coronavirus vaccine
SYDNEY (Reuters) - The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc and Germany's BioNTech <22UAy.F>, with delivery potentially as early as the first quarter of 2021.
